SOSV portfolio company SynPlexity acquired by Azenta
SynPlexity, a firm within the SOSV San Francisco ecosystem, has been acquired by Azenta Life Sciences.
See the latest news and media coverage for SOSV. We track all announcements, press releases, and industry mentions in real time, all in one place.
Pre-seed deep-tech venture capital firm
sosv.comLast updated
In short: SOSV pushed Physical AI investing, launched HAX Plasma Forge, rebranded, and scaled deep-tech funding.
SynPlexity, a firm within the SOSV San Francisco ecosystem, has been acquired by Azenta Life Sciences.
The company develops a human cell design and manufacturing platform to advance solutions for drug discovery, cell therapy, and regenerative medicine.
The AI platform supports workforce readiness and competency management; the contract funds its next development phase, starting with the Royal Canadian Air Force's CC-130J Hercules fleet.
SOSV raised a $306 million fund, supported portfolio companies raising $1 billion, expanded facilities, and hosted multiple events to boost deep tech startups.
SOSV was founded by Irish-American investor Sean O’Sullivan and is based in Princeton, New Jersey. It makes around 200 investments per year, from pre-seed to...
The climate tech investor is expanding its focus on early-stage startups that it thinks are developing the next wave of decarbonization solutions.
VC firm founded by former Dragons’ Den star has backed over 20 Irish companies...
SOSV manages over $700 million (€629.6 million) with a portfolio of over 900 start-ups. Mr O'Sullivan created the VC in 1995 after the IPO of...
Track SOSV and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to SOSV and other trending companies.